文献速递垂体与肾上腺疾病

术后第1天晨皮质醇作为预测库欣病长期缓解的生物标志物

Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究纳入260例库欣病患者,通过逻辑回归和Kaplan-Meier生存分析,评估术后皮质醇等指标与长期缓解的关系。

要点

  • 术后第1天晨血清皮质醇与库欣病复发显著相关。
  • 以术后第1天晨皮质醇<5 μg/dL为切点可预测长期缓解。
  • 女性及增殖指数亦与复发显著相关。

核心结论

  • 术后第1天晨血清皮质醇水平与库欣病复发显著相关。

研究设计与样本

  • 回顾性分析260例库欣病患者,采用逻辑回归和Kaplan-Meier生存分析,以复发为因变量。

主要发现

  • 以术后第1天晨血清皮质醇<5 μg/dL为切点,Kaplan-Meier分析显示其与长期缓解显著相关。

关键数值与推荐

  • 术后第1天晨血清皮质醇<5 μg/dL作为预测长期缓解的切点。

临床怎么用

  • 术后第1天晨血清皮质醇可用于识别库欣病术后长期缓解概率较高的患者。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Recurrence of Cushing disease (CD) can occur even decades after surgery. Biomarkers to predict recurrence of CD after surgery have been studied but are inconclusive. OBJECTIVE: The aim of our study was to identify specific biomarkers that can predict long-term remission after neurosurgery. DESIGN: Identification of specific biomarkers to predict long-term remission of CD was performed by logistic regression analysis followed by Kaplan-Meier survival analysis, using recurrence as the dependent variable. SETTING: A total of 260 patients with CD identified from our institutional research patient data registry search tool and from patients who presented to our longitudinal multidisciplinary clinic between May 2008 and May 2018 underwent statistical analysis. INTERVENTIONS: Data on clinical features, neuro-imaging study, pathology, biochemistry, and treatments were collected by reviewing digital chart records. MAIN OUTCOME MEASURE: Postoperative cortisol as a biomarker to predict long-term remission after surgical treatment for CD. RESULTS: By logistic regression analysis, postoperative day 1 (POD1) morning (5-10 am) serum cortisol, female sex, and proliferative index had significant association with CD recurrence (odds ratio [OR] = 1.025, 95% CI: 1.002-1.048, P = .032). In contrast, the postoperative nadir cortisol (OR = 1.081, 95% CI: 0.989-1.181, P = .086), urinary free cortisol (OR = 1.032, 95% CI: 0.994-1.07, P = .098), and late night salivary cortisol (OR = 1.383, 95% CI: 0.841-2.274, P = .201) had no significant correlation with recurrence. A significant association between POD1 morning serum cortisol and long-term CD remission was verified by Kaplan-Meier analysis when using POD1 morning serum cortisol <5 μg/dL as the cut-off. CONCLUSIONS: The POD1 morning serum cortisol level has a significant association with CD recurrence.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang F, Catalino MP, Bi WL, et al. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab. 2021. PMID: 33108450. doi:10.1210/clinem/dgaa773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。